Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Laken (Brussel), Belgium Clinical Trials

A listing of Laken (Brussel), Belgium clinical trials actively recruiting patients volunteers.

RESULTS

Found (40) clinical trials

The EVARREST Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study

This is an open label, prospective, randomised, multicentre, controlled, clinical study comparing EVARREST to SURGICEL (oxidized regenerated cellulose (ORC)) (Control) as an adjunct to haemostasis when conventional methods of controlling mild or moderate bleeding are ineffective or impractical during surgery in paediatric patients. At least 40 qualified paediatric subjects with …

Phase

0.51 miles

Learn More »

Efficacy Safety and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.

This clinical study will test the effects of a drug called apremilast in oligoarticular psoriatic arthritis with less than 2 years of disease duration. In previous studies, apremilast has been shown to be safe and efficacious in reducing signs and symptoms of psoriatic arthritis, as well as improving physical function. …

Phase

0.51 miles

Learn More »

Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.

Title "PREDICTUMAB: Predictive factors and magnitude of response to omalizumab and mepolizumab in allergic and eosinophilic severe asthma: a multicenter, open, active-controlled, randomized trial in adult patients in Belgium". Rationale and background New treatments are now available to treat severe refractory asthma, which affects about 3 to 5% of asthma …

Phase

0.51 miles

Learn More »

Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment

A multicentre, randomized, open-label comparative trial evaluating topical treatment options versus oral systemic treatment in adult patients suffering from localized neuropathic pain (LNP) syndromes. A wide variety of peripheral neuropathic pain syndromes will be included such as post-herpetic neuralgia (PHN), post-surgical NP/post-traumatic NP/scar pain, post-amputation NP, post-radiation therapy NP, complex …

Phase

0.51 miles

Learn More »

Randomized Placebo-controlled Double Blind Study to Evaluate the Efficacy of 2LVERU JUNIOR and 2LVERU on the Treatment of Warts.

The study duration will be maximum 21 months with 12 months of inclusion and 9 months of follow-up. Patients aged 3 years and older who present common warts (Verruca vulgaris), and/or plantar warts (Verruca plantaris), and/or flat warts (Verruca plana) during a visit with their dermatologist/general practitioner. The total number …

Phase

0.51 miles

Learn More »

Randomized Placebo-controlled Double-blind Study of 2LHERP in Orofacial Herpes Infections.

The study duration will be maximum 24 months with 12 months of inclusion and 12 months of follow-up. Patients aged between 18 and 80 years who present recurrent orofacial herpes infections (6 or more episodes within the 12-months' period prior to their study entry). The total number of patients to …

Phase

0.51 miles

Learn More »

N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms

This study investigates the effects of repeated NAC administration on glutamate concentrations in the anterior cingulate cortex (ACC), on neurocognitive functioning, and on neuro-inflammatory parameters in adult cannabis-dependent individuals.

Phase

1.02 miles

Learn More »

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height

Estrogens are responsible for the disappearance of growth cartilage in the long bones at the end of the pubertal growth spurt both in boys and in girls. It is therefore hypothesized that stopping pubertal development and hence estrogen production, will prolong and increase the pubertal growth spurt, especially when growth …

Phase

1.02 miles

Learn More »

Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation

Methodology: - A 5-year, multicentre, prospective, randomized, open-label, controlled study - Group 1: Simulect + cyclosporine + Myfortic + steroid stop at 3 months - Group 2: Simulect + cyclosporine (decrease dose in one week at month 3 and replace by everolimus) + Myfortic + steroid maintenance. - In both …

Phase

1.02 miles

Learn More »

Study of Sustained Benefit of Erenumab in Adult Episodic Migraine Patients

The primary objective is to demonstrate the superiority of subcutaneous erenumab compared to oral prophylactic(s) on sustained benefit defined as % subjects completing one-year on the randomized treatment and achieving at least a 50% reduction from baseline in monthly migraine days at month 12.

Phase

1.02 miles

Learn More »